Carotid Stenting Is Inferior to Carotid Endarterectomy in the Low Physiologic Risk Population: Results of the National Inpatient Sample, 2004-7  by Lane, John S. et al.
Abstracts from the 2010 Western Vascular Society
Annual MeetingCarotid Stenting Is Inferior to Carotid Endarterectomy in the Low
Physiologic Risk Population: Results of the National Inpatient Sample,
2004-7
John S. Lane, III, MD, Cheryl P. Magno, Andrew R. Barleben, Karen T.
Lane, Ninh T. Nguyen and Roy M. Fujitani, MD, Vascular Surgery, UC
Irvine, Orange, CA, and Orange, CA
Objective: The SAPPHIRE trial established that carotid artery stenting
(CAS) is not inferior to carotid endarterectomy (CEA) for patients at high
surgical risk. TheCREST trial has shownCEAhas a lower stroke rate thanCAS,
at the expense of higher cardiac complications. The objective of this studywas to
evaluate the nationwide performance of CAS and CEA in both high-risk (HR)
and low-physiologic-risk (LR) patients, outside of the clinical trial setting.
Methods:Data from theNational Inpatient Sample (NIS) were pooled
for patients undergoing carotid intervention from 2004-2007. HR was
defined as preexisting cardiac disease (CHF, valvular disease) or COPD.
Stroke, death, myocardial infarction, and complication rates were deter-
mined in both HR and LR populations. Multivariate regression analysis was
performed to determine adjusted odds of stroke and death.
Results: From 2004-2007, CEA was performed in 490,665 patients
(HR, 30.6%) and CAS in 50,283 patients (HR, 31.2%). Unadjusted stroke/
death rates were higher for CAS vs CEA in both HR and LR groups (Table).
Myocardial infarction rates were equivalent in the HR population and
slightly higher for CAS in the LR population. Combined complication rates
were higher after CEA vs CAS, mainly due to pulmonary and renal compli-
cations. Multivariate regression analysis revealed adjusted odds of stroke/
death were increased for CAS (OR, 1.36; CI, 1.28-1.45). HR patients had
an equivalent odds of stroke/death after CAS (OR, 1.10; CI, 0.99-1.28),
whereas LR patients had an increased odds (OR, 1.56; CI, 1.45-1.67).
Conclusions: This nationwide, real-world study supports the use of
CAS in the HR population undergoing carotid intervention. However, the
LR population is at higher risk of stroke and death after CAS compared with
CEA. Contrary to the CREST results, both carotid procedures can be
performed with equivalent cardiac morbidity.
EEGMonitoring with SSEPObviates Need for Shunting in CEA, even
with Stroke
Anna Weiss, MD, Anjali Scholten, MD, Jeffrey H. Gertsch, Katherine E.
Brown, MD, and Niren Angle, MD, Surgery, UC San Diego, San Diego,
CA, and San Diego, CA
Objective: The utilization of selective cerebral shunting during carotid
endarterectomy (CEA) has been predicated on surrogate measures such as
contralateral carotid occlusion, back-pressure measurements, and the patient’s
motor and cognitive function with regional anesthesia or recent stroke. This
study analyzed the need for shunting in CEA where comprehensive electroen-
cephalography (EEG) monitoring with somatosensory evoked potentials
(SSEP) was the sole determinant of the necessity of a shunt.
Design: A retrospective review was performed in a single institution of
all consecutive CEAs performed between September 2002 andMarch 2010.
The decision for carotid shunting was based only on changes in continuous
EEG dynamics reflecting ischemia as assessed intraoperatively by a neurolo-
gist. SSEP were used in a portion of cases as a functional confirmation of
EEG findings. No other factor influenced the need for a shunt. Patient
demographics, including age, degree of internal carotid artery (ICA) steno-
Table. Chi-square analysis of carotid interventions
Outcome, % (No.)
High risk (165,741)
CEA
(150,053)
CAS
(15,688)
Stroke/death 4.60 (6908) 6.14 (964)
Stroke/death/MI 7.84 (11,765) 8.99 (1,410)
Complications
MI 3.61 (5416) 3.45 (541)
Pulmonary 3.02 (4529) 1.01 (158)
Renal 0.73 (1092) 0.41 (65)
Combined 6.56 (9838) 4.52 (709) .sis, preoperative neurologic symptoms, and medications were reviewed.
Thirty-day outcomes, including stroke, TIA, death, and other major com-
plications were tabulated.
Results: A total of 163 patients (100 [62.5%] men; mean age 69.4
years, [range, 44-91]) underwent 169 carotid endarterectomies. Of the total
arteries treated, 76 (45%) were symptomatic, of which 66 (39%) had a
documented stroke. A total of 20 patients (11.8%) had high-grade contralat-
eral (80%-99%) ICA stenosis and 12 (7%) had contralateral ICA occlusion.
Only two shunts (1.2%) were used. The 30-day stroke, TIA, death rates were
four (2.3%), zero (0%), and two (1.2%), respectively. There was one intra-
operative stroke and the other three strokes occurred30 days. None of the
patients with contralateral occlusion or contralateral high-grade ICA steno-
sis had EEG changes necessitating a shunt.
Conclusion: Continuous EEG monitoring with SSEP dramatically
reduces the need to place a shunt during CEA. Recent stroke, contralateral
ICA occlusion, or contralateral high-grade ICA stenosis are not an indica-
tion for intraoperative shunting. Shunting for CEA should be vanishingly
rare. EEGwith SSEP should be considered the gold standard for monitoring
of cerebral perfusion during CEA.
Spatial Distribution of Microemboli Following Carotid Interventions
Wei Zhou, MD, Angela R. Laird, PhD, Simon B. Eickhoff, Mickle Fox,
Garrett Chan, Barton Lane, MD, Ronald Dalman, MD, and Allyson Rosen,
PhD, Surgery, StanfordUniversity, Stanford, CA, San Antonio, TX, Aachen,
Germany, Palo Alto, CA, and Stanford, CA
Background: Despite the absence of clinically evident neurologic
symptoms, subclinical microemboli during carotid interventions are com-
mon. Characterizing the typical locations of these lesions is an important
step in identifying neural systems vulnerable to disruption. The purpose of
this study was to examine the distribution of microemboli after carotid
interventions using a novel imaging analysis program.
Methods: Patients who received both preoperative and postoperative
MRI evaluations for carotid interventions at a single academic institution
from 2002 to 2008 were retrospectively evaluated. Microemboli were
defined by new hyperintensities on postoperative diffusion-weighted MRI
sequence (DWI) with corresponding decreased diffusion on the ADC map.
Microemboli regions of interest (ROI) were manually defined (MRICron)
and normalized using SPM5 along with ADC images. ROIs were smoothed
using a conservative Gaussian distribution (FWHM  6 mm) with FSL and
input to a modified version of the Anatomic Likelihood Analysis (ALE)
algorithm, in which a voxel-wise statistic was computed to derive a measure
of agreement across images.
Results: Inter-rater reliability was first established between a board-
certified neuroradiologist with experience detecting microemboli and a
novice rater trained to adequate inter-rater reliability with respect to micro-
embolus volume (R2  0.99) and spatial overlap (similarity index  0.80).
Among 160 patients who underwent carotid interventions and received
both preoperative and postoperative MRI studies, 81 had new postoperative
DWI lesions. Areas with a high degree of convergence across ROIs included
the anterior and posterior cingulate, middle frontal gyrus, insula, basal
ganglia, and occipital areas (Brodmann areas 18 and 19; Fig).
Conclusion: Regions vulnerable to microemboli include those impli-
cated in executive control and motor planning/speeded responses (anterior
P
Low risk (375,207)
P
CEA
(340,612) CAS(34,595)
001 3.61 (12,286) 5.91 (2.044) .001
001 5.52 (18,797) 8.27 (2861) .001
312 2.06 (7.012) 2.66 (921) .001
001 1.04 (3540) 0.39 (136) .001
001 0.72 (2437) 0.16 (54) .001.
.
.
.
.001 3.56 (12,121) 3.12 (1081) .001
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